This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Jul 15;59(7):1018-26.

doi: 10.1002/art.23813.

Health state utility values: a description of their development and application for rheumatic diseases

Nick Bansback¹, Mark Harrison, John Brazier, Linda Davies, Jacek Kopec, Carlo Marra, Deborah Symmons, Aslam Anis

Affiliations

PMID: 18576311
DOI: 10.1002/art.23813

Review

Health state utility values: a description of their development and application for rheumatic diseases

Nick Bansback et al. Arthritis Rheum. 2008.

. 2008 Jul 15;59(7):1018-26.

doi: 10.1002/art.23813.

Authors

Nick Bansback¹, Mark Harrison, John Brazier, Linda Davies, Jacek Kopec, Carlo Marra, Deborah Symmons, Aslam Anis

Affiliation

¹ Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.

PMID: 18576311
DOI: 10.1002/art.23813

No abstract available

PubMed Disclaimer

Similar articles

Functional measures in children with rheumatic diseases.
Murray KJ, Passo MH. Murray KJ, et al. Pediatr Clin North Am. 1995 Oct;42(5):1127-54. doi: 10.1016/s0031-3955(16)40056-8. Pediatr Clin North Am. 1995. PMID: 7567189 Review.
An overview of disability.
Fitzpatrick F, Badley EM. Fitzpatrick F, et al. Br J Rheumatol. 1996 Feb;35(2):184-7. doi: 10.1093/rheumatology/35.2.184. Br J Rheumatol. 1996. PMID: 8612033 Review. No abstract available.
Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?
Ruperto N. Ruperto N. J Rheumatol. 2007 Mar;34(3):463-5. J Rheumatol. 2007. PMID: 17343299 No abstract available.
Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore.
Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J. Luo N, et al. Ann Acad Med Singap. 2003 Sep;32(5):685-90. Ann Acad Med Singap. 2003. PMID: 14626802
Outcome measures in inflammatory rheumatic diseases.
Fransen J, van Riel PL. Fransen J, et al. Arthritis Res Ther. 2009;11(5):244. doi: 10.1186/ar2745. Epub 2009 Oct 14. Arthritis Res Ther. 2009. PMID: 19849821 Free PMC article. Review.

See all similar articles

Cited by

The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
Meacock R, Dale N, Harrison MJ. Meacock R, et al. Pharmacoeconomics. 2013 Jan;31(1):49-61. doi: 10.1007/s40273-012-0007-4. Pharmacoeconomics. 2013. PMID: 23329592
The burden of illness of rheumatoid arthritis.
Boonen A, Severens JL. Boonen A, et al. Clin Rheumatol. 2011 Mar;30 Suppl 1:S3-8. doi: 10.1007/s10067-010-1634-9. Epub 2011 Feb 26. Clin Rheumatol. 2011. PMID: 21359507 Review.
How important is mode of administration in treatments for rheumatic diseases and related conditions?
Bansback N, Trenaman L, Harrison M. Bansback N, et al. Curr Rheumatol Rep. 2015 Jun;17(6):514. doi: 10.1007/s11926-015-0514-3. Curr Rheumatol Rep. 2015. PMID: 25903666 Review.
Systematic review of health state utility values for acute myeloid leukemia.
Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G. Forsythe A, et al. Clinicoecon Outcomes Res. 2018 Jan 25;10:83-92. doi: 10.2147/CEOR.S153286. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 29416365 Free PMC article.
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review.
Meregaglia M, Nicod E, Drummond M. Meregaglia M, et al. Eur J Health Econ. 2023 Sep;24(7):1151-1216. doi: 10.1007/s10198-022-01541-y. Epub 2022 Nov 5. Eur J Health Econ. 2023. PMID: 36335234 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

MC_U145080960/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley